Skip to main content

Vascular 2023 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

HF

HF

Type here to filter the list

(VP002) A COST-UTILITY ANALYSIS OF HEART FAILURE REDUCED EJECTION FRACTION SEQUENCING STRATEGIES

Favorite
(VP033) DESIGN AND CHARACTERIZATION OF A PATIENT-CUSTOMIZABLE POLYMERIC CARDIAC VALVE PROSTHESIS FOR SURGICAL OR TRANSCATHETER IMPLANTATION

Favorite
(VP034) DETERMINANTS OF OUTCOME TO DISEASE-MODIFYING THERAPY FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY

Favorite
(VP048) EVALUATION OF PHARM-HF, A PHARMACIST-LED HEART FAILURE MEDICATION TITRATION CLINIC.

Favorite
(VP051) EXTERNAL VALIDATION OF AI PRIMARY GRAFT DYSFUNCTION PREDICTION CALCULATOR

Favorite
(VP061) IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON QUALITY OF LIFE IN HEART FAILURE ACROSS THE EJECTION FRACTION SPECTRUM: SYSTEMATIC REVIEW AND META-ANALYSIS

Favorite
(VP067) INTERRUPTIONS IN TRASTUZUMAB THERAPY FOR BREAST CANCER ARE ASSOCIATED WITH ADVERSE CARDIOVASCULAR AND ONCOLOGIC OUTCOMES.

Favorite
(VP076) MULTIPARAMETRIC RESPONSE TO DISEASE-MODIFYING THERAPY FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY

Favorite
(VP109) THE CANADIAN HEART FAILURE (CAN-HF) REGISTRY: A CANADIAN MULTI-CENTRE, RETROSPECTIVE STUDY OF OUTPATIENTS WITH HEART FAILURE

Favorite
(VP125) UNDERUTILIZATION OF INTRAVENOUS IRON IN A CONTEMPORARY POPULATION OF AMBULATORY HEART FAILURE PATIENTS IN CANADA

Favorite
(CCSP057) A COMPREHENSIVE TRANSITIONAL CARE PROGRAM FOR HEART FAILURE PATIENTS REDUCES HOSPITAL READMISSION

Favorite
(CCSP058) A DIAGNOSTIC SCREENING ALGORITHM FOR THE IDENTIFICATION OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN HIGH-RISK PATIENT POPULATIONS: UPDATED RESULTS

Favorite
(CCSP059) A PRESCRIBING PHARMACIST AND NURSE LED MEDICATION OPTIMIZATION CLINIC VERSUS USUAL CARE ON OPTIMIZATION OF GUIDELINE DIRECTED MEDICAL THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION

Favorite
(CCSP060) ASSOCIATIONS BETWEEN ANEMIA AND CLINICAL OUTCOMES IN CARDIAC AMYLOIDOSIS

Favorite
(CCSP061) BRINGING CARE CLOSE TO HOME: REMOTE MANAGEMENT OF HEART FAILURE IN PARTNERSHIP WITH INDIGENOUS COMMUNITIES IN NORTHERN ONTARIO

Favorite
(CCSP062) COMPARISON OF MACHINE LEARNING AND CONVENTIONAL STATISTICAL MODELING FOR PREDICTING READMISSION FOLLOWING ACUTE HEART FAILURE HOSPITALIZATION

Favorite
(CCSP063) DETERMINING THE UTILITY OF THE CACHEXIA SCORE (CASCO) STAGING TOOL FOR CARDIAC CACHEXIA IN A HEART FAILURE POPULATION

Favorite
(CCSP064) DOES THE METHOD OF CALCULATING THE 30-DAY READMISSION RATE AFTER HOSPITALIZATION FOR HEART FAILURE MATTER? DATA FROM THE VANCOUVER COASTAL ACUTE HEART FAILURE (VOCAL-AHF)

Favorite
(CCSP065) EARLY REAL-WORLD EXPERIENCE WITH THE NEW CARDIAC MYOSIN INHIBITOR MAVACAMTEN FOR SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN A SINGLE CANADIAN TERTIARY CARE CENTER

Favorite
(CCSP066) EVALUATING THE UTILITY OF H2FPEF SCORES IN OLDER PATIENTS WITH SUSPECTED PULMONARY HYPERTENSION AND CARDIOVASCULAR RISK FACTORS

Favorite
(CCSP067) FACTORS IMPACTING PHYSICIAN PROGNOSTIC ACCURACY IN HEART FAILURE PATIENTS WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION

Favorite
(CCSP068) INDUCTION THERAPY IN HEART TRANSPLANTATION: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Favorite
(CCSP069) INOTROPE VERSUS PLACEBO THERAPY IN CARDIOGENIC SHOCK: THE CAPITAL DOREMI2 TRIAL

Favorite
(CCSP070) IMPLEMENTATION OF A SPECIALIZED HEART FUNCTION INPATIENT UNIT TO OPTIMIZE PATIENT CARE AND STAFF/LEARNER SATISFACTION

Favorite
(CCSP071) LONG-TERM OUTCOMES OF TRANSCATHETER TRICUSPID VALVE REPAIR IN PROHIBITIVE RISK PATIENTS: FUTILITY OR BENEFIT?

Favorite
(CCSP073) MUSCLE SYMPATHETIC EXCITATORY RESPONSES TO DYNAMIC ONE-LEG CYCLING EXERCISE ARE AUGMENTED IN HEART FAILURE WITH PRESERVED EJECTION FRACTION

Favorite
(CCSP074) OUTCOMES OF SEPTAL REDUCTION THERAPY IN A NEWLY ESTABLISHED MULTIDISCIPLINARY HYPERTROPHIC CARDIOMYOPATHY PROGRAM: THE BRITISH COLUMBIA EXPERIENCE

Favorite
(CCSP075) OUTPATIENT MEDICATION OPTIMIZATION AND THE IMPACT ON LEFT VENTRICULAR EJECTION FRACTION RECOVERY: AN ANALYSIS OF RECENTLY DIAGNOSED HEART FAILURE PATIENTS FOLLOWED AT A TERTIARY CARE CENTRE

Favorite
(CCSP076) PENTRAXIN-3 AS A NOVEL CARDIOTOXIC BIOMARKER FOR BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINES AND THE IMPACT OF PHYSICAL ACTIVITY: AN INTERIM REPORT FROM THE EXACT 2.0 TRIAL

Favorite
(CCSP077) PROGNOSTIC VALUE OF PULMONARY HYPERTENSION IN PATIENTS WITH LOW-FLOW LOW-GRADIENT AORTIC STENOSIS

Favorite
(CCSP078) RESIDUAL TRICUSPID REGURGITATION AFTER EDGE-TO-EDGE REPAIR AS PROGNOSTIC PARAMETER FOR LONG-TERM CLINICAL OUTCOMES

Favorite
(CCSP079) ROLE OF THE INTERLEUKIN-37 IN PREVENTIN AF-ASSOCIATED INFLAMMATION AND FIBROSIS IN HEART DISEASES

Favorite
(CCSP080) TACKLING CORONARY MICROVASCULAR DYSFUNCTION IN HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION

Favorite
(CCSP081) THE IMPACT OF FOUR PILLAR MEDICAL OPTIMIZATION ON CARDIAC BIOMARKERS AND STRUCTURAL PARAMETERS IN HEART FAILURE WITH REDUCED EJECTION FRACTION

Favorite
(CCSP082) THE RECARDIO TRIAL PROTOCOL: COMPARING THE EFFECTS OF COGNITIVE TRAINING AND PHYSICAL EXERCISE ON COGNITION AND CEREBRAL AUTOREGULATION IN MEN AND WOMEN WITH HEART FAILURE

Favorite
(CCSP083) THE ROLE OF EXERCISE DURING HEMODYNAMIC ASSESSMENT TO IMPROVE PULMONARY HYPERTENSION DIAGNOSIS IN OLDER ADULTS

Favorite
(CCSP084) ULTRASOUND OF QUADRICEPS FEMORIS AS A VALID TOOL FOR MALNUTRITION SCREENING IN HEART FAILURE CLINICS

Favorite
(CCSP085) VIRTUAL VISITS EVAULATION IN HEART FUNCTION CLINICS

Favorite